G Fraisse

Délégation Paris 7

Papers

1

Total Citations

29

H-Index

1

About

Dr. G. Fraisse is a leading urologic surgeon and researcher whose work centers on the comparative effectiveness of minimally invasive treatments for renal cell carcinoma. His major contributions lie in rigorously comparing robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA) for T1 renal tumors. In his most cited work (29 citations), Fraisse and his team conducted a landmark retrospective study matching patients on radiological stage and renal score, providing crucial evidence on peri-operative and local control outcomes. This research directly informs clinical decision-making for patients and surgeons weighing surgical resection against ablation. Beyond this, Fraisse’s broader portfolio examines oncological outcomes and surgical techniques in urologic oncology, with a focus on optimizing cancer control while minimizing morbidity. His work has been instrumental in defining the risk-benefit profiles of these competing technologies, helping to establish evidence-based treatment algorithms. For students and researchers, Fraisse exemplifies how careful comparative effectiveness research can translate into practical, patient-centered improvements in cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
29
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Peri‐operative and local control outcomes of robot‐assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score
29 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Délégation Paris 7

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago